Roche Faces Stock Drop Suit Over Cancer Drug Results
Roche was hit with a potential shareholder class action in New Jersey federal court on Tuesday, alleging that the drugmaker misrepresented to investors the effectiveness of a breast cancer treatment under...To view the full article, register now.
Already a subscriber? Click here to view full article